A Systematic Review of Hepatitis Virus Review Studies: A Case of Health Economic Evaluation Analysis

Abstract

Objective: Systematic reviews of economic analysis are necessary for assessing reports and making a decision. A systematic review of systematic reviews is mean of summarizing the current evidence across specialties of the same or very similar intervention, to provide a synthesis treatment effect. The aim of this study was to explore and to assess the quality of systematic reviews conducted hepatitis economic evaluation.Methods: This study was designed as a systematic review following the AMSTAR guideline through Medline, Cochrane, and Science Direct databases. It was scoped in publication period of 2001 and 2016 in international journals. The quality assessment of the included studies was based on AMSTAR checklist. Two authors did the appreciation independently and all the different results were solved by discussion to give the conclusion.Results: 851 publications found, only 25 studies of those met the inclusion criteria. These studies consisted of 5 studies for vaccination and 20 for non-vaccination. There were only 16% (n=4) based on PRISMA guideline; and twenty-one studies (64%) were not showing about the method of the systematic review or not based on any guideline. Only three articles has published in 2016 with a high standard. Conclusion:According to the results of the appraisal AMSTAR checklist, this review shows clearly the current situation and an urgent need for an increase of quality of hepatitis virus review studies based on health economic evaluation.

Cost-Effectiveness of Hla-B*5701 Prospective Genetic Screening of Hypersensitivity to Abacavir

“…To improve the effectiveness of treatment, a useful method was the economic evaluation in health research [13]. Thus, the question of the pharmacoeconomic efficiency of using the prospective HLA-B* 5701 screening needs a deeper study, which determined the purpose and objectives of our study.…”